To meet the urgent need to expand laboratory capacity, the Centers for Medicare & Medicaid Services yesterday announced a relaxed enforcement policy under the Clinical Laboratory Improvement Amendments during the COVID-19 public health emergency with respect to review of pathology slides, proficiency testing, alternate collection devices, and requirements for a CLIA certificate. Among other flexibilities, CMS said the policy will enable:

  • Pathologists to review pathology slides remotely if certain defined conditions are met;

  • U.S. laboratories performing COVID-19 testing that apply for CLIA certification to begin testing as quickly as possible; and

  • Laboratories within a hospital/university hospital campus to hold a single CLIA certificate for the laboratory sites within the same physical location or street address

Related News Articles

Headline
The Centers for Disease Control and Prevention updated its page on COVID-19 transmission to clarify other types of spread beyond person to person, such as by…
Headline
The Food and Drug Administration yesterday updated guidance to spur wider availability of alcohol-based hand sanitizers during the COVID-19 pandemic. The…
Headline
The Health Resources and Services Administration today awarded $20.3 million to increase the number of fellows at accredited addiction medicine and addiction…
Headline
The Centers for Medicare & Medicaid Services yesterday implemented several new infection control actions to combat COVID-19 in nursing homes. One…
Headline
The AHA today asked the Department of Health and Human Services to distribute substantial additional emergency funds to hospitals and health systems in an…
Headline
An estimated 9.5% of U.S. residents, or 30.7 million people, lacked health insurance when surveyed in the first six months of 2019, according to preliminary…